Currà , A.; Gasbarrone, R.; Bonifazi, G.; Serranti, S.; Fattapposta, F.; Trompetto, C.; Marinelli, L.; Missori, P.; Lendaro, E.
Near-Infrared Transflectance Spectroscopy Discriminates Solutions Containing Two Commercial Formulations of Botulinum Toxin Type A Diluted at Recommended Volumes for Clinical Reconstitution. Biosensors 2022, 12, 216.
https://doi.org/10.3390/bios12040216
AMA Style
Currà A, Gasbarrone R, Bonifazi G, Serranti S, Fattapposta F, Trompetto C, Marinelli L, Missori P, Lendaro E.
Near-Infrared Transflectance Spectroscopy Discriminates Solutions Containing Two Commercial Formulations of Botulinum Toxin Type A Diluted at Recommended Volumes for Clinical Reconstitution. Biosensors. 2022; 12(4):216.
https://doi.org/10.3390/bios12040216
Chicago/Turabian Style
Currà , Antonio, Riccardo Gasbarrone, Giuseppe Bonifazi, Silvia Serranti, Francesco Fattapposta, Carlo Trompetto, Lucio Marinelli, Paolo Missori, and Eugenio Lendaro.
2022. "Near-Infrared Transflectance Spectroscopy Discriminates Solutions Containing Two Commercial Formulations of Botulinum Toxin Type A Diluted at Recommended Volumes for Clinical Reconstitution" Biosensors 12, no. 4: 216.
https://doi.org/10.3390/bios12040216
APA Style
Currà , A., Gasbarrone, R., Bonifazi, G., Serranti, S., Fattapposta, F., Trompetto, C., Marinelli, L., Missori, P., & Lendaro, E.
(2022). Near-Infrared Transflectance Spectroscopy Discriminates Solutions Containing Two Commercial Formulations of Botulinum Toxin Type A Diluted at Recommended Volumes for Clinical Reconstitution. Biosensors, 12(4), 216.
https://doi.org/10.3390/bios12040216
